Each page teaches what a test measures, how the method works, what a COA result can support, and where the result stops. The emphasis is analytical evidence, not medical or performance claims.
The starting guide explains what a peptide COA is, why identity, purity, amount, contaminants, microbiology, and stability are separate questions, and which stronger modern signals can improve on a familiar report row.
Reviewed COA examples use UV/Vis language for identity, purity, and quantitative assay, plus heavy-metals, TAMC, and TYMC rows. Those rows can be educationally useful, but modern peptide quality work often needs more specific methods: LC-MS for identity, chromatographic impurity profiling, calibrated assay, element-specific ICP-MS, and microbiology controls matched to the claim being made.
Identity, purity, assay, and degradation profiles describe the peptide signal.
Elemental impurities and residual solvents look for process-related residues.
TAMC, TYMC, sterility, and endotoxin answer different microbial questions.
These pages map directly to the COA rows already visible in current COA workflows, then explain the more specific analytical methods that can strengthen the evidence.
Identity testing asks whether the material in the vial is the intended peptide. LC-MS adds molecular-mass and fragmentation evidence that a UV/Vis lambda-max row cannot provide by itself.
9 min read
Purity is not just a big percentage. It is the fraction of detected signal assigned to the main component under a specific separation, detector, wavelength, and integration method.
10 min read
Quantitative assay asks how much peptide is actually present. It is the section that connects a chromatographic or spectroscopic response to an amount per vial.
9 min read
Heavy metals testing is best treated as elemental impurity risk control: what elements could be present, at what concentration, and under what validated detection method.
8 min read
TAMC and TYMC report recoverable microbial growth under defined media and incubation conditions. They are enumeration categories, not sterility tests.
8 min readThese tests should not be casually implied. They become important when the product claim, manufacturing route, sample state, or release question calls for them.
Sterility testing asks a different question than microbial counts: did viable microorganisms grow from the tested units after incubation under sterility-test conditions?
9 min read
Endotoxin testing detects lipopolysaccharide activity from gram-negative bacterial material. It is a different risk signal than sterility or microbial count.
8 min read
Residual solvent testing asks whether volatile process solvents remain in the material after synthesis, purification, drying, or formulation.
8 min read
Stability testing asks how the peptide changes with time, temperature, light, oxidation, humidity, or solution state. It is the bridge between a single COA snapshot and a shelf-life claim.
9 min readThese articles explain test methods and COA interpretation. They do not state that any peptide is safe, effective, sterile, injectable, therapeutic, approved, compliant, or fit for human or animal use. Method pages should be read as analytical education only.
These pages are general analytical education only. They are not medical, safety, legal, regulatory, quality-system, purchasing, or product-use advice, and they do not state that any material is safe, effective, sterile, injectable, therapeutic, approved, compliant, or fit for human or animal use.
